93 related articles for article (PubMed ID: 20187715)
21. Effects of oral enalapril and verapamil on dialysis adequacy and solute clearance in chronic ambulatory peritoneal dialysis.
Atabak S; Taziki O; Argani H; Abolghasemi R; Zangneh HF; Rahmani L
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1170-4. PubMed ID: 24231479
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
Clerbaux G; Francart J; Wallemacq P; Robert A; Goffin E
Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
[TBL] [Abstract][Full Text] [Related]
23. Drain volume required for a target peritoneal clearance: formulae based on peritoneal transport type and body size.
Tzamaloukas AH; Malhotra D; Murata GH
ASAIO J; 1998; 44(6):828-34. PubMed ID: 9831093
[TBL] [Abstract][Full Text] [Related]
24. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
25. Tranexamic acid increases peritoneal ultrafiltration volume in patients on CAPD.
Kuriyama S; Nakayama M; Tomonari H; Kawaguchi Y; Hosoya T
Perit Dial Int; 1999; 19(1):38-44. PubMed ID: 10201339
[TBL] [Abstract][Full Text] [Related]
26. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
[TBL] [Abstract][Full Text] [Related]
27. Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure.
de Alvaro F; Castro MJ; Dapena F; Bajo MA; Fernandez-Reyes MJ; Romero JR; Jimenez C; Miranda B; Selgas R
Adv Perit Dial; 1993; 9():56-61. PubMed ID: 8105963
[TBL] [Abstract][Full Text] [Related]
28. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
[TBL] [Abstract][Full Text] [Related]
29. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
[TBL] [Abstract][Full Text] [Related]
30. High flux peritoneal membrane is a risk factor in survival of CAPD treatment.
Wu CH; Huang CC; Huang JY; Wu MS; Leu ML
Adv Perit Dial; 1996; 12():105-9. PubMed ID: 8865883
[TBL] [Abstract][Full Text] [Related]
31. Estimating the daily dialysate drain volume required in CAPD for a target peritoneal creatinine clearance by body water and peritoneal transport characteristics.
Rao P; Tzamaloukas AH; Murata GH; Piraino B; Malhotra D; Bernardini J; Oreopoulos DG
Adv Perit Dial; 1997; 13():33-7. PubMed ID: 9360647
[TBL] [Abstract][Full Text] [Related]
32. Ultrafiltration capacity and peritoneal fluid kinetics in continuous ambulatory peritoneal dialysis patients.
Zhe XW; Tian XK; Cheng L; Wang T
Artif Organs; 2008 Jan; 32(1):61-5. PubMed ID: 18181804
[TBL] [Abstract][Full Text] [Related]
33. The effect of angiotensin II receptor blocker on peritoneal membrane transports in continuous ambulatory peritoneal dialysis patients.
Jearnsujitwimol V; Eiam-Ong S; Kanjanabuch T; Wathanavaha A; Pansin P
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S188-95. PubMed ID: 17044472
[TBL] [Abstract][Full Text] [Related]
34. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years.
Faller B; Lameire N
Nephrol Dial Transplant; 1994; 9(3):280-6. PubMed ID: 8052436
[TBL] [Abstract][Full Text] [Related]
35. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study.
Szeto CC; Law MC; Wong TY; Leung CB; Li PK
Am J Kidney Dis; 2001 Feb; 37(2):329-36. PubMed ID: 11157374
[TBL] [Abstract][Full Text] [Related]
36. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
37. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
Hung SY; Chung HM
Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
[TBL] [Abstract][Full Text] [Related]
38. Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysis.
Yoshimoto K; Saima S; Nakamura Y; Nakayama M; Kubo H; Kawaguchi Y; Nishitani H; Nakamura Y; Yasui A; Yokoyama K; Kuriyama S; Shirai D; Kugiyama A; Hayano K; Fukui H; Horigome I; Amagasaki Y; Tsubakihara Y; Kamekawa T; Ando R; Tomura S; Okamoto R; Miwa S; Koyama T; Echizen H
Clin Nephrol; 1998 Aug; 50(2):90-3. PubMed ID: 9725779
[TBL] [Abstract][Full Text] [Related]
39. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis.
Strauss FG; Holmes DL; Dennis RL
Adv Perit Dial; 1995; 11():110-3. PubMed ID: 8534681
[TBL] [Abstract][Full Text] [Related]
40. The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients.
Szeto CC; Lai KB; Chow KM; Szeto CY; Li PK
J Nephrol; 2005; 18(2):197-203. PubMed ID: 15931648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
